mHealth and Home Monitoring - Berg Insight

モバイルヘルスとホームモニタリング 第13版

mHealth and Home Monitoring - 13th Edition


出版 Berg Insight
出版年月 2026年10月
ページ数 420
図表数 108
価格 記載以外のライセンスについてはお問合せください
 シングルユーザ EUR 1,800
 企業ライセンス EUR 3,600
種別 英文調査報告書
商品番号 SMR-30094


SEMABIZ - otoiawase8

世界市場における家庭用コネクテッド医療モニタリング機器の利用台数は、2025年末時点で9,270万台に達しました。今後、年平均成長率(CAGR)11.5%で増加し、2030年には1億5,970万台に達するとBerg Insightでは予測しています。

Berg Insight「モバイルヘルスとホームモニタリング 第13版 – mHealth and Home Monitoring – 13th Edition」は健康管理向け無線ソリューション市場を調査し、関連企業情報や市場予測などを提供しています。

主な掲載内容

  1. 慢性疾患の課題
    1. 概説
    2. 一般的な慢性疾患
    3. 医療提供者と医療費償還制度
    4. 規制環境
  2. モバイルヘルスプラットフォーム
    1. モバイルヘルスの接続ソリューション
      1. Alphabet
      2. Apple
      3. AT&T
      4. Bittium
      5. Deutsche Telekom
      6. eDevice
      7. Enovacom (Orange)
      8. KORE Wireless
      9. MedM
      10. Microsoft
      11. Telefónica
      12. Telenor
      13. Tenovi
      14. Vodafone
    2. モバイルヘルスケアデリバリープラットフォーム
      1. Alira Health
      2. Aptar Digital Health
      3. Clario
      4. Doccla
      5. Domicalis
      6. Enovation (Legrand Care)
      7. Hope Care
      8. Huma Therapeutics
      9. Luscii, an OMRON Healthcare Service
      10. Medisanté
      11. Medixine
      12. S3 Connected Health
      13. TruBridge (IKS Health)
  3. 生理学的モニタリングソリューションの提供企業
    1. 医療機器と遠隔モニタリング
    2. 心調律管理
    3. 心電図の遠隔モニタリング(リモートECGモニタリング)
    4. 血圧モニタリング
    5. 抗凝固モニタリング
    6. コネクテッド型睡眠療法
    7. 在宅睡眠診断
    8. 血中酸素モニタリング
    9. 気流モニタリング
    10. 血糖モニタリング&インスリン投与
    11. その他生理学的モニタリングソリューション
  4. 薬物治療、AED、統合型モニタリングソリューションの提供企業
    1. テレヘルス&マルチパラメータモニタリングソリューション
    2. 薬物治療コンプライアンスモニタリング
    3. コネクテッド型自動体外式除細動器
  5. 市場分析と予測
    1. 市場予測
    2. 収益予測
    3. 市場成長促進要因と阻害要因
    4. 業界動向と分析

Report Overview

mHealth and Home Monitoring is the thirteenth consecutive report from Berg Insight that gives first-hand insights into the adoption of wireless solutions for health monitoring. This strategic research report from Berg Insight provides you with 420 pages of unique business intelligence including 5-year industry forecasts and expert commentary on which to base your business decisions.

How should the mobile industry address the vast business opportunity in wireless healthcare monitoring? The number of connected home medical monitoring devices in use on the global market was 92.7 million at the end of 2025 and is forecasted to grow at a CAGR of 11.5 percent to reach 159.7 million in 2030. Learn more about how wireless technology can become seamlessly integrated with medical devices in this 420-page in-depth report now in its thirteenth edition.

This report will allow you to

  • Profit from 43 new executive interviews with market leading companies.
  • Learn about key home health monitoring devices and services.
  • Study the strategies of 152 key players in the mHealth ecosystem.
  • Understand the dynamics of the health monitoring market in Europe and North America.
  • Comprehend how wireless technology can become seamlessly integrated with medical devices.
  • Evaluate the business opportunities in the emerging mHealth segment.
  • Predict future market and technology developments.

The number of connected home medical monitoring devices reached 92.7 million in 2025

mHealth refers to the application of telecommunications in medicine and includes everything from connected medical devices to digital care programs. The adoption of mHealth solutions in healthcare is driven by a wide range of incentives, related to everything from demographics and technology development to new advancements in medical treatment. The primary focus of this report is on home monitoring solutions, which are commonly used to manage patients with various chronic conditions such as cardiac arrhythmia, diabetes, hypertension, respiratory diseases and sleep apnoea. Other applications include remote diagnostics, compliance monitoring and clinical trials.

The number of connected home medical monitoring devices reached 92.7 million in 2025, reflecting growing market acceptance. This number includes all connected medical devices used in mHealth care programs. Berg Insight estimates that the number of connected home medical monitoring devices will grow at a compound annual growth rate (CAGR) of 11.5 percent to 159.7 million by 2030. Cellular connectivity remains the de facto standard communications technology for most types of connected home medical monitoring devices and will account for 89.5 million connections in 2030. However, the use of patients’ own mobile devices (BYOD) as connectivity hubs for remote patient monitoring is increasing and has become the preferred connectivity option in several segments, such as diabetes management. By 2030, a total of 68.4 million patients will rely on BYOD connectivity.

Berg Insight estimates that revenues for remote patient monitoring (RPM) solutions reached € 50.4 billion in 2025, including revenues from medical monitoring devices and mHealth software and services. RPM revenues are expected to grow at a CAGR of 12.7 percent between 2025 and 2030 to reach € 91.6 billion at the end of the forecast period. Connected medical devices accounted for 51 percent of total RPM revenues in 2025. However, revenues for mHealth software and services are growing at a faster rate and will account for 54 percent of total revenues in 2030, up from 49 percent in 2025.

There is a strong trend towards incorporating greater connectivity into medical devices to enable new services and value propositions. Sleep therapy is by far the most connected segment and is dominated by ResMed. Additional vendors include Philips, BMC Medical, Löwenstein Medical Technology. The number of monitored patients continues to grow and has more than doubled since 2018, largely due to the compliance monitoring requirements that have been introduced in the US and Europe. Implantable cardiac rhythm management (CRM) has traditionally been the largest market segment, led by companies such as Medtronic, Abbott, Boston Scientific and BIOTRONIK, which began including connectivity in CRM solutions two decades ago. Berg Insight anticipates that the fastest growing market segments in the next five years to be remote ECG monitoring, diabetes management and medication compliance monitoring. Today, the leading connected healthcare players in these segments include forward-thinking incumbents as well as innovative new entrants such as AliveCor, Abbott, Bardy Diagnostics, Boston Scientific, Biotricity, Compliance Meds Technologies, Dignio, Evondos, Philips, Dexcom, Glooko, GE Healthcare, Hero Health, Insulet, iRhythm Technologies, InfoBionic.Ai, MedMinder, MedReady, Medtronic, MiniMed, Roche, Tandem Diabetes Care, WellDoc and Withings.

mHealth software and services are one of the most rapidly developing parts of the mHealth value chain. This segment includes platforms for remote patient monitoring, which utilise connected devices like wearables and sensors to track vital signs and health metrics. Service providers in this space offer comprehensive solutions that integrate data analytics, telehealth capabilities and patient engagement tools to ensure continuous and efficient care. Companies that specialise in this area include Amwell, Aptar Digital Health, Alira Health (Bepatient), CareSimple, Current Health, Doccla, Huma Therapeutics, OMRON Healthcare (Luscii), Medisanté, MedM, S3 Connected Health, SHL Telemedicine, Teladoc Health, Tellihealth, Enovation (Legrand Care), Vivalink and Welldoc.

The global healthcare sector is undergoing a technological transformation driven by changing patient needs, rising healthcare costs and an ageing population. The market is shifting towards a connected, decentralised and patient-centric model of care. The COVID-19 pandemic accelerated the adoption of telehealth and remote patient monitoring (RPM), as these digital technologies are becoming the new standard for care delivery. Since then, providers are incorporating social care models into public health systems to better address patient needs. Medical providers and technology companies are seeking ways to revolutionise care by streamlining costs, reducing hospital readmission rates and expanding access to care in remote areas. The focus is increasingly moving from episodic care towards continuous monitoring and proactive intervention. Healthcare providers are adopting remote and home-based care models to improve patient outcomes, reduce avoidable hospitalisations and readmissions, manage healthcare costs and extend access to specialist care. Artificial intelligence (AI) has advanced significantly, aiding in disease detection and personalised treatment by analysing large datasets. This shift supports the move from data collection to proactive and personalised solutions. Additionally, using patients’ own mobile devices as health hubs has become a viable alternative. Berg Insight predicts that this transformation will drive strong growth in the mHealth industry over the next five years.

Table of Contents

Executive Summary

1 The Challenge of Chronic Diseases

1.1 Introduction
1.1.1 The ageing population
1.1.2 Lifestyle-related diseases
1.2 Common chronic diseases
1.2.1 Cardiovascular diseases and risk factors
1.2.2 Chronic respiratory diseases
1.2.3 Sleep-related breathing disorders
1.2.4 Metabolic diseases and risk factors
1.2.5 Neurological disorders
1.3 Healthcare providers and reimbursement systems
1.3.1 Healthcare in Asia-Pacific
1.3.2 Healthcare in Europe
1.3.3 Healthcare in North America
1.4 Regulatory environment
1.4.1 Regulatory environment in Europe
1.4.2 Regulatory environment in North America
1.4.3 Regulatory environment in other major markets
1.4.4 International standardisation

2 mHealth Platforms

2.1 Overview of the mHealth market
2.1.1 mHealth market segments
2.1.2 Connectivity options for medical devices
2.1.3 The mHealth technology value chain
2.2 mHealth connectivity solutions
2.2.1 Alphabet
2.2.2 Apple
2.2.3 AT&T
2.2.4 Bittium
2.2.5 Deutsche Telekom
2.2.6 eDevice
2.2.7 Enovacom (Orange)
2.2.8 KORE Wireless
2.2.9 MedM
2.2.10 Microsoft
2.2.11 Telefónica
2.2.12 Telenor
2.2.13 Tenovi
2.2.14 Vodafone
2.3 mHealth care delivery platforms
2.3.1 Alira Health
2.3.2 Aptar Digital Health
2.3.3 Clario
2.3.4 Doccla
2.3.5 Domicalis
2.3.6 Enovation (Legrand Care)
2.3.7 Hope Care
2.3.8 Huma Therapeutics
2.3.9 Luscii, an OMRON Healthcare Service
2.3.10 Medisanté
2.3.11 Medixine
2.3.12 S3 Connected Health
2.3.13 TruBridge (IKS Health)

3 Physiological Monitoring Solution Providers

3.1 Medical devices and remote monitoring
3.1.1 Medical device revenues by market segment
3.1.2 Overview of the remote patient monitoring market
3.2 Cardiac rhythm management
3.2.1 Overview of the CRM device market
3.2.2 Use cases for CRM monitoring
3.2.3 Remote monitoring solution providers
3.2.4 Abbott
3.2.5 BIOTRONIK
3.2.6 Boston Scientific
3.2.7 Medtronic
3.2.8 MicroPort CardioFlow Medtech
3.3 Remote ECG monitoring
3.3.1 Overview of the remote ECG monitoring device market
3.3.2 Use cases for remote ECG monitoring
3.3.3 Remote monitoring solution providers
3.3.4 AliveCor
3.3.5 Biotricity
3.3.6 Boston Scientific Cardiac Diagnostics
3.3.7 CardioComm Solutions
3.3.8 GE HealthCare
3.3.9 InfoBionic.Ai
3.3.10 iRhythm Technologies
3.3.11 LevMed
3.3.12 Philips Ambulatory Monitoring & Diagnostics (BioTelemetry)
3.3.13 TZ Medical
3.3.14 VitalConnect
3.3.15 Zenicor Medical Systems
3.4 Blood pressure monitoring
3.4.1 Overview of the blood pressure monitoring device market
3.4.2 Use cases for blood pressure monitoring
3.4.3 Remote monitoring solution providers
3.4.4 A&D Holon Holdings Company
3.4.5 iHealth Labs
3.4.6 Microlife
3.4.7 OMRON Healthcare
3.4.8 Rossmax
3.4.9 Smart Meter
3.4.10 Welch-Allyn (Baxter International)
3.4.11 Withings
3.5 Coagulation monitoring
3.5.1 Overview of the coagulation monitoring device market
3.5.2 Use cases for blood coagulation monitoring
3.5.3 Remote monitoring solution providers
3.5.4 Abbott (Acelis Connected Health)
3.5.5 CoaguSense
3.5.6 Helena Laboratories
3.5.7 iLine Microsystems
3.5.8 Roche Diagnostics
3.5.9 Siemens Healthineers
3.5.10 Werfen
3.6 Connected sleep therapy
3.6.1 Overview of the sleep therapy device market
3.6.2 Use cases for sleep therapy monitoring
3.6.3 Remote monitoring solution providers
3.6.4 BMC Medical
3.6.5 Fisher & Paykel Healthcare
3.6.6 Good Sleep Co
3.6.7 Löwenstein Medical Technology
3.6.8 Philips Sleep and Respiratory Care
3.6.9 ResMed
3.6.10 Sefam
3.6.11 Somnics Health
3.6.12 SomnoMed
3.6.13 Vestalis
3.7 Home sleep diagnostics
3.7.1 Overview of the home sleep diagnostics market
3.7.2 Use cases for home sleep diagnostics
3.7.3 Remote monitoring solution providers
3.7.4 Acurable
3.7.5 Beacon Biosignals
3.7.6 Belun Technology
3.7.7 BioSerenity
3.7.8 Cadwell Laboratories
3.7.9 Compumedics
3.7.10 EnsoData
3.7.11 Huxley Medical
3.7.12 Natus Medical
3.7.13 Nox Medical (Nox Health)
3.7.14 Onera Health
3.7.15 SOMNOmedics
3.7.16 Wesper
3.7.17 Zoll Itamar (part of Zoll Medical)
3.8 Blood oxygen monitoring
3.8.1 Overview of the blood oxygen monitoring device market
3.8.2 Use cases for blood oxygen monitoring
3.8.3 Remote monitoring solution providers
3.8.4 BodiMetrics
3.8.5 ChoiceMMed
3.8.6 Masimo (Danaher)
3.8.7 Nonin Medical
3.9 Airflow monitoring
3.9.1 Overview of the air flow monitoring device market
3.9.2 Use cases for airflow monitoring
3.9.3 Remote monitoring solution providers
3.9.4 Adherium
3.9.5 Aluna (Huma Therapeutics)
3.9.6 AstraZeneca
3.9.7 Medical International Research (MIR)
3.9.8 Monitored Therapeutics
3.9.9 NIOX Group
3.9.10 Sibelmed
3.9.11 Smart Respiratory
3.9.12 Vitalograph
3.9.13 Vitasora Health
3.10 Glucose monitoring and insulin delivery
3.10.1 Overview of the glucose monitoring device market
3.10.2 Use cases for glucose monitoring
3.10.3 Remote monitoring solution providers
3.10.4 Abbott Diabetes Care
3.10.5 Ascensia Diabetes Care
3.10.6 Dexcom
3.10.7 Glooko
3.10.8 Insulet
3.10.9 LifeScan
3.10.10 MiniMed
3.10.11 Roche Near Patient Care
3.10.12 Senseonics
3.10.13 Sequel Med Tec
3.10.14 Tandem Diabetes Care
3.10.15 Welldoc
3.11 Other physiological monitoring solutions
3.11.1 Implantable medical devices
3.11.2 Home haemodialysis
3.11.3 Thermometers and weight scales
3.11.4 Mental health
3.11.5 Cholesterol monitoring
3.11.6 Incontinence monitoring
3.11.7 Seizure alarms and monitors

4 Medication, AED and Integrated Monitoring Solution Providers

4.1 Telehealth and multiparameter monitoring solutions
4.1.1 Overview of the telehealth solutions market
4.1.2 Use cases for telehealth solutions
4.1.3 Telehealth solution providers
4.1.4 AMC Health
4.1.5 Amwell
4.1.6 CareSimple
4.1.7 Current Health
4.1.8 Health Recovery Solutions
4.1.9 Medtronic
4.1.10 Philips Enterprise Informatics
4.1.11 SHL Telemedicine
4.1.12 Teladoc Health
4.1.13 Tellihealth
4.1.14 TytoCare
4.1.15 Vivalink
4.2 Medication compliance monitoring
4.2.1 Overview of the medication compliance monitoring market
4.2.2 Use cases for medication compliance monitoring
4.2.3 Compliance monitoring solution providers
4.2.4 AdhereTech
4.2.5 Axitare
4.2.6 CareHome Health Solutions
4.2.7 Compliance Meds Technologies
4.2.8 Dignio
4.2.9 etectRx
4.2.10 Evondos
4.2.11 Hero Health
4.2.12 iZafe Group
4.2.13 MedMinder (PersonalRX)
4.2.14 MedReady
4.2.15 Merck Group
4.2.16 Mevia
4.2.17 PharmAdva (MedaCube)
4.2.18 RGF Diagnostics (Mymemo)
4.2.19 Spencer Health Solutions
4.2.20 Tamro (PHOENIX Group)
4.2.21 Wisepill Technologies
4.3 Connected automated external defibrillators
4.3.1 Overview of the connected defibrillator market
4.3.2 Use cases for automated external defibrillators
4.3.3 Connected solution providers
4.3.4 Almas Industries
4.3.5 Avive Solutions
4.3.6 Cardia International (Skanray)
4.3.7 CardiLink
4.3.8 Heartstream (formerly Philips Emergency Care)
4.3.9 Metrax
4.3.10 Mindray Medical
4.3.11 Nihon Kohden
4.3.12 PYRESCOM
4.3.13 Schiller
4.3.14 Stryker
4.3.15 Zoll Medical (Asahi Kasei)

5 Market Analysis and Forecasts

5.1 Market forecasts
5.1.1 Cardiac rhythm management
5.1.2 Sleep therapy
5.1.3 Remote ECG monitoring
5.1.4 Glucose monitoring and insulin delivery
5.1.5 Medication compliance monitoring
5.1.6 Other medical devices
5.2 Revenue forecasts
5.2.1 Medical monitoring devices
5.2.2 mHealth software and services
5.3 Market drivers and barriers
5.3.1 An ageing population increases the demand for care services
5.3.2 Increase of non-communicable disease prevalence
5.3.3 The generational technology barrier is disappearing
5.3.4 Healthcare staff shortages call for more efficient healthcare
5.3.5 Government policy and reimbursement are accelerating adoption of mHealth
5.3.6 Transformation to value-based care
5.3.7 Increased focus on disease prevention
5.3.8 Advances in therapeutics create new monitoring opportunities
5.3.9 The critical role of cybersecurity in digital solutions
5.3.10 Increased need for interoperability as the number of solutions grows
5.4 Industry trends and analysis
5.4.1 The role of AI and ML in transforming mHealth
5.4.2 Integrations are becoming crucial in the health data ecosystem
5.4.3 Increasing adoption of wearable devices for continuous home monitoring
5.4.4 Consumerisation of medical-grade mHealth devices and apps
5.4.5 Cellular technologies enable reliable connectivity for medical devices
5.4.6 Major pharmaceutical companies prepare large-scale rollouts
5.4.7 BYOD is becoming a popular and viable option
5.4.8 The global adoption of telehealth is ramping up
5.4.9 Compliance monitoring is a major driver behind home monitoring
5.4.10 COVID-19 accelerated the structural adoption of mHealth
5.4.11 M&As and strategic partnerships strengthen the connected care ecosystem

Glossary

List of Figures

Figure 1.1: Population by age group and region (EU & North America 2024–2050) …. 6
Figure 1.2: Number of people suffering from chronic diseases (EU & North America 2025) … 8
Figure 1.3: Prevalence of adult diabetes (20–79 years) by region (World) …….. 15
Figure 1.4: Share of the population covered by private health insurance (2024) …. 20
Figure 1.5: Total health expenditure per capita by country (2024) ……… 21
Figure 1.6: Health insurance coverage by type of insurance (US 2024) …… 26
Figure 1.7: Total and per capita healthcare expenditure by country (North America 2024) … 28
Figure 1.8: Healthcare spending by type of service and product (Canada 2024) …… 29
Figure 2.1: mHealth market segments ……………. 39
Figure 2.2: Connected medical devices and the provision of care …….. 42
Figure 2.3: Overview of the mHealth technology value chain ………. 43
Figure 2.4: The main focus areas of mHealth connectivity solution providers …… 45
Figure 2.5: Examples of apps compatible with Google’s health ecosystem …… 48
Figure 2.6: Examples of apps available on the App Store by focus area …….. 51
Figure 2.7: HealthGO telehealth hub …………… 60
Figure 2.8: MedM RPM platform, mobile apps and caregiver portal ……… 68
Figure 2.9: Tenovi cellular gateway …………….. 74
Figure 2.10: HeroTracker Sense digital solution …………. 80
Figure 2.11: Medixine Suite ……………… 99
Figure 3.1: Medical device market revenues by segment (World 2024–2030) …… 107
Figure 3.2: Connected medical devices by segment (World 2025) …….. 108
Figure 3.3: Implantable cardiac rhythm management vendor market shares (2025) ….. 109
Figure 3.4: Examples of implantable CRM devices ………… 110
Figure 3.5: The Medtronic MyCareLink patient monitor ……….. 111
Figure 3.6: Market shares for remote monitoring of CRM implants (2025) …… 112
Figure 3.7: The Merlin.net interface, Merlin@home transmitter and the myMerlinPulse app .. 113
Figure 3.8: BIOTRONIK’s Home Monitoring Service Center data transmission ….. 116
Figure 3.9: LATITUDE NXT Wave wireless communicator ………. 117
Figure 3.10: MyCareLink Heart data transmission to clinics ………. 119
Figure 3.11: MCT sensor and monitor from Philips ………… 123
Figure 3.12: Implantable Cardiac Monitors from Medtronic ……….. 124
Figure 3.13: AliveCor’s products and Kardia App………… 128
Figure 3.14: HeartCheck devices ……………. 134
Figure 3.15: Examples of blood pressure monitors ………… 150
Figure 3.16: A&D connected products and Heart Track app ……… 153
Figure 3.17: OMRON Healthcare’s connected product family ………. 157
Figure 3.18: The VitalSight kit for remote patient monitoring ……… 159
Figure 3.19: Withings connected devices, data hub and RPM solution …….. 165
Figure 3.20: The Coag-Sense PT2 meter……………. 171
Figure 3.21: Sleep therapy vendor market shares (2025) ……….. 176
Figure 3.22: ResMed AirSense 11 CPAP device and myAir app ………. 179
Figure 3.23: Connected sleep therapy solutions by vendor (2025) …….. 180
Figure 3.24: Philips DreamMapper mobile application ………. 187
Figure 3.25: ResMed myAir with the Care Check-In and Personal Therapy Assistant …. 191
Figure 3.26: iNAP Sleep Therapy System …………… 195
Figure 3.27: SomnoDent Classic ……………. 197
Figure 3.28: Zoll Itamar’s connected home sleep monitoring device …….. 201
Figure 3.29: Examples of home sleep diagnostics companies and products …. 204
Figure 3.30: SleepView Monitor ……………… 207
Figure 3.31: Compumedics’ home sleep testing devices ………… 213
Figure 3.32: The Nox A1s Device ……………. 219
Figure 3.33: The iSpO2 oximeter and MightySat device and application …….. 227
Figure 3.34: Masimo SafetyNet workflow……………. 228
Figure 3.35: The Hailie platform ……………… 235
Figure 3.36: Aluna spirometer device and mobile application ………. 237
Figure 3.37: GoSpiro spirometer device ………….. 242
Figure 3.38: Vitasora Health’s device and app …………. 248
Figure 3.39: Blood glucose meter vendor market shares (2025) ……… 251
Figure 3.40: CGM and insulin delivery system vendor market shares (2025) ….. 252
Figure 3.41: Glucose meters from Livongo and Roche ………… 254
Figure 3.42: Dexcom CGM system ……………. 255
Figure 3.43: MiniMed Flex System automated insulin delivery system …… 256
Figure 3.44: Connected glucose monitoring and insulin delivery system by vendor (2025) … 257
Figure 3.45: Examples of connected blood glucose meters ………. 259
Figure 3.46: Examples of connected CGM and insulin pump systems…… 261
Figure 3.47: FreeStyle Libre 3 CGM system ………….. 262
Figure 3.48: Dexcom G7 family ……………. 266
Figure 3.49: The Glooko Transmitter ……………. 269
Figure 3.50: Insulet Omnipod 5……………. 271
Figure 3.51: Accu-Chek SmartGuide CGM solution ……….. 278
Figure 3.52: Roche mySugr app …………….. 279
Figure 3.53: Tandem Mobi insulin pump system …………. 284
Figure 3.54: Welldoc BlueStar……………… 286
Figure 4.1: Overview of the telehealth and multiparameter monitoring landscape …… 295
Figure 4.2: Compliance monitoring solution form factors ……….. 321
Figure 4.3: Connected medication compliance solutions by vendor (2025) ……. 322
Figure 4.4: The AdhereTech smart pill bottle …………. 323
Figure 4.5: Axitare medication dispenser (new generation) ……….. 325
Figure 4.6: Graciela smart medication management device ………. 327
Figure 4.7: The CleverCap Lite and Pro devices …………. 328
Figure 4.8: ID-Capsule and Reader …………… 332
Figure 4.9: The Evondos Anna medicine dispenser robot ………. 334
Figure 4.10: Hero pill dispenser and Hero mobile app ………. 337
Figure 4.11: Dosell medication dispenser ………….. 339
Figure 4.12: The MedMinder pill dispenser …………… 342
Figure 4.13: The Easypod injector and the Easypod transmitter ……… 345
Figure 4.14: Medose and Mepill from Mevia ………….. 346
Figure 4.15: Mymemo automatic pill dispenser ………… 349
Figure 4.16: The Spencer SmartHub ……………. 350
Figure 4.17: Smila medication robot …………….. 352
Figure 4.18: Wisepill RT3000 Dispenser ………….. 353
Figure 4.19: AED registries ………………. 357
Figure 4.20: The DOC defibrillator …………….. 358
Figure 4.21: CardiLink application interface ………….. 361
Figure 5.1: Connected home medical monitoring devices (World 2024–2030) ….. 371
Figure 5.2: Connected home medical monitoring devices by region (World 2024–2030) …. 372
Figure 5.3: Connected cardiac rhythm management devices (World 2024–2030) …… 373
Figure 5.4: Connected sleep therapy devices (World 2024–2030) ……… 374
Figure 5.5: Connected ECG monitoring devices (World 2024–2030) …….. 375
Figure 5.6: Connected glucose monitoring & insulin delivery devices (World 2024–2030) .. 377
Figure 5.7: Connected medication monitoring solutions (World 2024–2030) ….. 378
Figure 5.8: Other connected medical devices (World 2024–2030) ……… 380
Figure 5.9: Remote patient monitoring revenues (World 2024–2030) …….. 381
Figure 5.10: Connected medical device revenues (World 2025–2030) …… 381
Figure 5.11: mHealth software and services revenues (World 2024–2030) …….. 383
Figure 5.12: Elderly population (65+) as a percentage of total population (World 2025) …. 385
Figure 5.13: Summary of CPT codes ……………. 389
Figure 5.14: Teleconsultation visits (France 2020–2024) ………… 412


    お問合せフォーム

    • *のある項目は必須項目です。

    • レポートのタイトルは自動で入ります。

    • 無料サンプルはご購入を検討されている方向けのレポート形式等確認用資料です。
      重要記述や数値は記載されていません。予めご了承ください。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    お問合せレポート

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    SEMABIZのプライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    inquiry(at)semabiz.co.jp


    関連記事